The Section of Cardio-respiratory Function was set up in October 1999. As a new section it consists of the section of electrocardiograph (ECG) and the section of pulmonary function. The medical staffs are composed of an associate chief physician, 2 attending physicians, 2 technicians-in-charge and a primary nurse.

The section undertakes several examinations for electro-cardiographic and pulmonary function tests. A total of 7 examinations include: a) twelfth lead ECG with isochronous automatic analysis; b) third lead bed-side ECG with isochronous automatic analysis; c) ECG with a 24-hour dynamic analysis; d) synthetic electrocardiographic analysis, including ECG frequency spectrum, late electric potential of the ventricle, alteration in heart rate, QT discrete variable, ECG vector, ECG with high frequency, ECG with time-vector, ECG for patients with pacemaker etc.; e) the system for dynamic blood analysis; f) pulmonary function tests, including vital capacity (VC), time VC, maximal voluntary ventilation, flow rate capacity, diffusion function, residual volume (RV) and automatic analysis of pulmonary function and g) drug test, mainly including the tests for propranolol and atropine.

The non-invasive hemodynamics examination has recently been developed to evaluate clinical and preoperative cardiac function. The dodeca-dynamic ECG , can correctly record and analyze a variety of electrocardiographic abnormalities, and identify various hidden pathologies of heart disease, with the examination of the late electric potential of ventricle, the variation of heart rate and the QT variable. The analytical system of ambulatory blood pressure will group and classify the patients with high blood pressure, providing data which will correctly give a full view of blood pressure, provide medical information for the perioperation period and evidence for timely treatment. The normalization of drug tests will discriminate an array of critical ECG from pathological changes.